방광으로의 침윤성 전이를 동반한 난소의 경계성 점액성 종양과 연관된 복막 위점액종 1예
A case of pseudomyxoma peritonei associated with borderline mucinous tumor of ovary with invasive metastasis of bladder
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
복막 위점액종은 드문 질환으로 다량의 점액성 물질이 복강과 골반강내 산재하며 장과 대그물망에 이식되는 것을 그 특징으로 한다. 임상적 증상은 대부분 복부 팽만, 소화불량, 복강내 촉지되는 종괴이다. 복막 위점액종은 주로 충수돌기나 난소의 종양에서 기원하고 드물게는 각각이 원발병소로 발견되는 경우도 있으나 아직 연구 중에 있다. 그 병인론이나 치료, 예후 역시 아직 확립되지 않은 상태이다. 복막위점액종은 충수돌기나 난소 외에 타 장기로의 전이가 거의 없다고 알려져 있으나 저자들은 방광으로의 침윤성 전이를 동반한 난소의 경계성 점액성 종양과 관련된 복막 위점액종 1예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.
Abstract
Pseudomyxoma peritonei (PMP) is an uncommon entity characterized by large amount of mucinous-jelatinous fluid disseminated in abdominal cavity and pelvic cavity with implants on omentum and bowel. The symptoms of this disease are mostly abdominal distension, dyspepsia, and intraabdominal palpable mass. The origin of PMP is under investigation yet, that is known to arise from appendix, ovary mostly. Also it’s etiology, treatment, and prognosis are speculative. Rare cases were reported that have invasion to other organ except appendix and ovaries, but we experienced a case of PMP associated with borderline mucinous tumor of ovary with invasive metastasis of bladder. So we report this case with a brief review with literature.
참고문헌 (15)
- Smeenk RM, "Appendiceal neoplasms and pseudomyxoma peritonei: a population based study", Eur J Surg Oncol, 34, pp.196~201 (2008)
- Ronnett BM, "Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary", Anat Pathol, 2, pp.197~226 (1997)
- Seidman JD, "Association of mucinous tumors of the ovary and appendix. A clinicopathologic study of 25 cases", Am J Surg Pathol, 17, pp.22~34 (1993)
- Werth R, "Pseudomyxoma peritonei", Arch Gynecol Obstet, 24, pp.100~118 (1884)
- Ronnett BM, "Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women", Int J Gynecol Pathol, 16, pp.1~9 (1997)
- Fernandez RN, "Pseudomyxoma peritonei", Arch Surg, 115, pp.409~414 (1980)
- Carmignani CP, "Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix", J Surg Oncol, 87, pp.162~166 (2004)
- Sulkin TV, "CT in pseudomyxoma peritonei: a review of 17 cases", Clin Radiol, 57, pp.608~613 (2002)
- Stewart JHt, "Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions", Ann Surg Oncol, 12, pp.765~777 (2005)
- Gough DB, "Pseudomyxoma peritonei. Long-term pa tient survival with an aggressive regional approach", Ann Surg, 219, pp.112~119 (1994)
- Miner TJ, "Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy", Ann Surg, 241, pp.300~308 (2005)
- Misdraji J, "Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases", Am J Surg Pathol, 27, pp.1089~1103 (2003)
- Jones CM 3rd, "Successful treatment of pseudomyxoma peritonei of ovarian origin with cis-platinum, doxorubicin, and cyclophosphamide", Gynecol Oncol, 22, pp.257~259 (1985)
- Chua TC, "Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy", J Clin Oncol, 30, pp.2449~2456 (2012)
- Verwaal VJ, "Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy", J Surg Oncol, 85, pp.61~67 (2004)